Prevalence of Strokes Secondary to a Reversible Cerebral Vasoconstriction Attributable to Cannabis Consumption in Young Subjects (≤ 45 Years) Hospitalized for an Ischaemic Stroke
试验速览
- 阶段
- 不适用
- 发起方
- 入组人数
- 300
- 试验地点
- 12
- 主要终点
- Evaluation Cannabis use
研究概览
简要总结
Incidence of strokes has increased these last 20 years in young population. This rise could be linked to alcohol, tobacco or drug use like cannabis. Cannabis has previously been descripted as a potential factor of reversible vasoconstriction. The main objective is to show that an exhaustive assessment of a stroke facing a young person frequently lead to a diagnostic of reversible vasoconstriction due to cannabis use. Evaluation will focus on prevalence of strokes secondary to a reversible vasoconstriction attributable to cannabis in young subjects.
There's a real public healthcare interest in terms of primary and secondary prevention to evaluate the role of cannabis as a risk factor of stroke in young population.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Prevention
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 45 Years（Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Subject between 18 and 45 years old
- •Stroke confirmed by medical imaging
- •Written informed consent (subject, nearby or emergency procedure)
- •Subject affiliate to a local healthcare insurance office
- •For female of childbearing potential, an adequate contraceptive measur
排除标准
- •Subject with psychiatric disorder, unable to understand the study or cooperate
- •Subject under guardianship or forfeiture of liberty
- •Pregnant or breastfeeding woman
- •Subject in period of exclusion due to another study or still in follow-up of an interventional study
研究组 & 干预措施
Cannabis User
干预措施: Drug urinal test (Other)
结局指标
主要结局
Evaluation Cannabis use
时间窗: 12 months
Reversible vasoconstriction on medical imaging of intracranial arteries at different moment
时间窗: 12 months.
medical imaging of intracranial arteries will show new stenoses (topography, number, evolution), and new ischemic or cerebral haemorrhagic lesions
次要结局
未报告次要终点